Market News & Analysis
Week Ahead: Coronavirus, FOMC, BOE, and Brexit
Joe Perry January 25, 2020 7:20 AM
Wow! I’m sure not many people expected a risk off move this week due to the outbreak of a virus! With 3 Central Bank meetings (BOC turned dovish) and a return to watching the economic data after US trade deals were signed (USMCA to be signed next week), the most dominant event this week which affected the markets was the Coronavirus. So far, the virus has killed 26 people and infected more than 900. China has quarantined cities and canceled many public events during its New Years Holiday, which is expected to take a hit on Q1 GDP. There have been 2 confirmed cases so far in the US.
On the opening next week, the focus will likely continue to be the Coronavirus. If there are more confirmed cases over the weekend, especially outside of China, we could see some markets gapping on the open.
There are two major Central Bank meetings next week, which include the US Federal Reserve and the Bank of England. The Fed is expected to hold and maintain its neutral view. However, the BOE may cut given the recent onslaught on bad data (however today’s PMI data may give them pause). In addition, this will be Mark Carney’s last meeting as Governor or the Bank of England. Will he cut rates at his last meeting, a la Jean Claude-Trichet of the ECB?
The ultimate event of the week will be the ceremonial Brexit, when the UK FINALLY leaves the EU. However, there are still deals to be made negotiations to be had, which will last until the end of the year.
Earnings reports continue through next week, with highlights including AAPL, MSFT, FB, TSLA, BA, AMZN, DB, XOM, CVX, and CAT
In addition, macro data for next week are as follows:
- German Ifo
- Australian NAB Consumer Confidence
- US Durable Goods
- Australian Inflation Data
- Crude Oil Inventories
- US Fed Interest Rate Decision
- BoE Interest Rate Decision
- US GDP Growth Rate QoQ Adv Q4 -this is the first look at the 4th Quarter GDP. 2.1% is expected
- Europe GDP Growth Rate QoQ Flash Q4. –first look at 4th Quarter GBP for the Eurozone. 0.2% is expected
- US PCE Price Index – this is one of the Fed’s favorite indicators of measuring inflation, however with the FED meeting two days prior, this number may not matter as much
Chart to Watch: S&P 500 E-mini Futures
Source: Tradingview, CME, City Index
The S&P 500 stock index is a good proxy to generalize how stocks are doing as a whole. On this weekly chart, price had moved higher last week and tested the top trendline of the upward sloping trend. In addition, it tested the 161.8% Fibonacci Retracement level from the highs in September 2018 to the lows of December 2018 near 3336.50. The 161.8% level is known at the “Golden Fib” level and should be closely monitored. Also, note that the RSI is (and has been) in overbought territory. The RSI turned lower this week, once it touched 80 (extreme overbought) as the market pulled back into the channel. On a daily chart, the RSI and price were actually diverging until today (not shown). Price can trade lower to near 3225, which is horizontal support and the bottom trendline before doing any technical damage.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.